RxDoctor Payments Data

Patricia Hall, MD

Family Medicine · Thomaston, GANPI 1932404662

Payments from drug & device makers

$9,432in general payments, 2019–2025

Across 627 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Pfizer$1K
  • AstraZeneca$885
  • Lilly USA, LLC$843
  • AbbVie$515
  • Amgen$421
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$9,423100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,432 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$114,696
Medicare patients
262
Services billed
2,889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide240$270,027
FarxigaDapagliflozin Propanediol198$192,088
JardianceEmpagliflozin162$188,649
EliquisApixaban200$176,194
Trelegy ElliptaFluticasone/Umeclidin/Vilanter207$146,843
MounjaroTirzepatide99$104,326
RybelsusSemaglutide48$80,518
Tresiba Flextouch U-200Insulin Degludec99$78,407
Breztri AerosphereBudesonide/Glycopyr/Formoterol104$66,262
TrulicityDulaglutide44$62,206
LinzessLinaclotide75$54,822
VraylarCariprazine Hcl34$48,943
XareltoRivaroxaban42$43,897
Repatha SureclickEvolocumab54$30,511
EntrestoSacubitril/Valsartan32$29,143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,984$350,545288 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$885$262,219317 claims
Boehringer IngelheimJardiance, Combivent Respimat$305$198,188181 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Shingrix$414$185,921292 claims
PfizerEliquis$1,009$176,194200 claims
Lilly USA, LLCMounjaro, Trulicity$843$166,532143 claims
AbbVieLinzess, Vraylar$515$103,765109 claims
Johnson & JohnsonXarelto$302$43,89742 claims
NovartisEntresto$189$29,14332 claims
MerckJanuvia, Dulera$108$27,98030 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$101$27,95926 claims
Astellas Pharma US IncMyrbetriq$18$26,77436 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Thomaston

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →